BioPharm International
October 01, 2010
Issue PDF
23
10
Biopharmaceutical Approvals in the US and EU: A Review
October 01, 2010
Outsourcing Insights
23
10
Venture capital is still scarce for early biotechs and their providers.
October 01, 2010
Downstream Trends
23
10
Can vendor-user partnerships overcome the typical wait-and-see attitude toward new technologies?
October 01, 2010
Features
23
10
Biotech approvals were up last year. Is it a sign of a new trend?
October 01, 2010
Final Word
23
10
How should the industry educate the public about product quality?
October 01, 2010
Regulatory Beat
23
10
A new strategy to streamline vaccine development and oversight.
October 01, 2010
From the Editor
23
10
Good leaders look beyond industry woes to focus on patients
October 01, 2010
Burrill on Biotech
23
10
Biotech's mid-sized elites position themselves for growth.
October 01, 2010
Features
23
10
Industry and regulators disagree over noncritical parameters.